Eric J. Loumeau, VP, Corporate General Counsel at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), sold 937 shares at $5.46 ($5K) on 2007-02-14, disclosed to the SEC on 2007-02-15.
Scheduled sale ($5k) by VP, Corporate General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.46 | 93 | $508 | 9.9% |
| 2 | $5.48 | 186 | $1K | 19.8% |
| 3 | $5.49 | 193 | $1K | 20.6% |
| 4 | $5.50 | 186 | $1K | 19.8% |
| 5 | $5.52 | 186 | $1K | 19.9% |
| 6 | $5.57 | 93 |
| $518 |
| 10.0% |
| Total | $5.50 avg | 937 | $5K | 100% |
| Filing → |
| ANAB | SELL | 2026-01-08 | $764K | — | Filing → |
| ANAB | SELL | 2026-01-06 | $129K | — | Filing → |
| ANAB | SELL | 2025-12-23 | $510K | — | Filing → |